API & Intermediates: |
|
Tenofovir & its intermediates |
CAS No:[202138-50-9] |
|
|
(R)-9-(2-phosphonylmethoxy propyl)adenine (R-PMPA) |
CAS No:[206184-49-8]
CAS No:[147127-20-6] |
|
Lamivudine & its intermediates |
CAS No:[134678-17-4] |
|
|
Cytosine |
CAS No:[71-30-7] |
|
|
L-Menthyl glyoxylate hydrate |
CAS No:[111969-64-3] |
|
|
(2S.5R)-5-Cytosine-1-yl-[1,3]-oxathiolane -2-carboxylic acid menthyl ester (CME) |
CAS No:[147027-10-9] |
|
|
Lamivudine salicylate |
CAS No:[173522-96-8] |
|
Emtricitabine & its intermediates |
CAS No:[143491-57-0] |
|
|
(2R,5R)-5-Hydroxy-[1,3]-oxathiolane-2-carboxylic acid menthyl ester (HME) |
CAS No:[147126-62-3] |
|
|
(2S,5R)-5-Fluoro cytosine-1-yl-[1,3]-oxathiolane-2-carboxylic acid menthyl ester (FCME) |
CAS No:[147126-75-8] |
|
Oseltamivir & its intermediates |
CAS No: [204255-11-8] |
|
|
(1s,5r,6s)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate |
CAS No: [204254-96-6] |
|
|
(3R,4r,5s)-4-n-acetyl(1,1-dimethylethyl)amino-5-n,n-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester monohydrochloride |
CAS No: [651324-08-2] |
|
Sofosbuvir & its intermediates |
CAS No: [1190307-88-0] |
|
|
(S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4 dihydropryimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2yl) methoxy)(phenoxy)phosphoryl)amino) propanoate (SOFO-1) |
CAS No:[1190307-88-0] |
|
|
(2'R)-N-BENZOYL-2' DEOXY-2' FLUORO-2'- METHYL CYTIDINE-3'5'-DIACETATE (Sofo C2) |
CAS No:[1649427-38-2] |
|
|
(2'R)-2'-Deoxy-2'-fluoro-2'-methyluridine (Sofo C1) |
CAS No:[863329-66-2] |
|
|
((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate |
CAS No:[874638-80-9] |
|
|
(2R)-2-Deoxy-2-fluoro-2-Methyl-D-erythro-pentonic acid-g-lactone 3,5-bis(4-chlorobenzoate) |
CAS No:[ 1294481-79-0] |
|
|
N4-Benzoylcytosine |
CAS No:[26661-13-2] |
|
|
((2R,3R,4R,5R)-5-(benzamido-2-oxopyrimidin-1(2H)-yl)-2-(benzoyloxymethyl)-4-fluoro-4-methyltetrahydrofuran-3-yl |
CAS No:[817204-32-3] |
|
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)-phenoxy-phosphinyl]-1-Methylethyl ester |
CAS No:[133451-02-8] |
|
|
(2s)-isopropyl -2-((perfluorophenoxyl) (phenoxy)phosphorylamino) Propanoate (Sofo 1) |
CAS No:[133451-02-8] |
|
|
L-Alanine isopropyl ester hydrochloride |
CAS No:[62062-65-1] |
|
Gemcitabine & its intermediates |
CAS No:[95058-81-4] |
|
|
3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-D-erythropentane-1,4-lactone |
CAS No:[122111-01-7] |
|
|
3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-1-O-
methanesulfonyl-D-ribofuranose |
CAS No:[122111-11-9] |
|
|
3',5'-Di-O-benzoyl-2',2'-difluoro-2'-deoxy
cytidine |
CAS No:[134790-39-9] |
|
Ticagrelor & its intermediates |
CAS NO:[274693-27-5] |
|
|
4,6-dichloro-2-propylthiopyrimidine-5-amine |
CAS No:[145783-15-9] |
|
|
(1S,2S,3R,5S)-3-[7-Chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy) |
CAS No:[1354945-69-9] |
|
|
2-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol |
CAS No:[376608-74-1] |
|
|
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yloxy)ethanol L-tataric acid |
CAS No:[376608-65-0] |
|
|
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine(2R)-Hydroxy(phenyl)ethanoate |
CAS No:[376608-71-8] |
|
Posaconazole & its intermediates |
CAS NO:[171228-49-2] |
|
|
2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one |
CAS No:[184177-83-1] |
|
|
(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester |
CAS No:[149809-43-8] |
|
|
1H-1,2,4-TRIAZOLE, 1-[[(2S)-2-(2,4-DIFLUOROPHENYL)OXIRANYL]METHYL]- |
CAS No:[141113-42-0] |
|
|
N'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide oxalate |
CAS No:[1887197-42-3] |
|
|
2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde |
CAS No:[170985-85-0] |
|
|
2-(2-(2,4-difluorophenyl)allyl)propane-1,3-diol |
CAS No:[165115-73-1] |
|
Voriconazole & its intermediates |
CAS NO:[137234-62-9] |
|
|
6-Ethyl-5-fluoropyrimidin-4(3H)-one |
CAS No:[137234-87-8] |
|
|
(2R,3S/2S,3R)-3-(4-Chloro-5-fluoro-6-pyrimidinyl)-2-(2,4-difluorophenyl)butan-2-ol hydrochloride |
CAS No:[188416-35-5] |
|
|
3-(6-Chloro-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride |
CAS No:[188416-20-8] |
|
|
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4-pyriMidinyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol |
CAS No:[188416-29-7] |
|
|
(2R,3S)-2-(2,4-Difluorophenyl)-3-(5-fluoropyriMidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol L(-)-CaMphorsulfonate |
CAS No:[137234-71-0] |
|
|
4-Amino-4H-1,2,4-triazole |
CAS No:[584-13-4] |
|
|
4-Chloro-6-ethyl-5-fluoropyrimidine |
CAS No:[137234-74-3] |
|
ApreMilast & its intermediates |
CAS NO:[608141-41-9] |
|
|
1,3-Dioxo-2-isoindolineaceticacid |
CAS No:[6296-53-3] |
|
|
3-Ethoxy-4-methoxy benzonitrile |
CAS No:[60758-86-3] |
|
|
(S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethanaMine |
CAS No:[608141-42-0] |
|
Dabigatran etexilate & its intermediates |
CAS NO:[211915-06-9] |
|
|
3-[(3-amino-4-methylamino-benzoyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
CAS No:[212322-56-0] |
|
|
Dabigatran ethyl AcOH Salt |
CAS No:[429658-95-7] |
|
|
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester |
CAS No:[211915-84-3] |
|
|
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride |
CAS No:[211914-50-0] |
|
Mirabegron & its intermediates |
CAS NO:[223673-61-8] |
|
|
(R)-2-[[2-(4-nitrophenyl ethyl] aMino]-1-phenyl ethanol Monohydrochloride |
CAS No:[521284-21-9] |
|
|
(AlphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride |
CAS No:[521284-22-0] |
|
Agomelatine & its intermediates |
CAS NO:[138112-76-2] |
|
|
2-(7-Methoxy-1-naphthyl)ethylamine hydrochloride |
CAS No:[139525-77-2] |
|
|
2-(7-Methoxy-1-naphthyl)acetonitrile |
CAS No:[138113-08-3] |
|
|
2-(7-Methoxynaphthalen-1-yl)acetic acid |
CAS No:[6836-22-2] |
|
Cidofovir & its intermediates |
CAS NO:[113852-37-2] |
|
|
P-[[(1S)-2-[4-(Benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid diethyl ester |
CAS No:[132336-36-8] |
|
|
(S)-N1-[(3-Dihydroxy-2-phosphonylMethoxy)propyl]-N4-benzoyl-cytosine |
CAS No:[132336-37-9] |
Other API: |
|
|
Colesevelam |
CAS No:[182815-44-7] |
|
|
Sildenafil |
CAS No:[139755-83-2] |
|
|
Lacosamide |
CAS No:[175481-36-4] |
|
|
Tolvaptan |
CAS No:[150683-30-0] |
|
|
Avanafil |
CAS No:[330784-47-9] |
|
|
Vonaprazan |
CAS No:[1260141-27-2] |
Other Intermediates: |
|
|
Trans-4-Aminocyclohexanol |
CAS No:[27489-62-9] |
|
|
2-Thiouracil |
CAS No:[141-90-2] |
|
|
2'-C-Methyluridine |
CAS No:[31448-54-1] |
|
|
1,2,3,5-Tetra-O-benzoyl-2-C-methyl-b-D-ribofuranose |
CAS No:[15397-15-6] |
|
|
6,6-DiMethyl-3-azabicyclo[3.1.0]hexane Boceprevir Key interMediate |
CAS No:[943516-54-9] |
|
|
Pyrrolo [1,2-f] [1,2,4] trizin-4-amine |
CAS No:[159326-68-8] |
|
|
(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)tetrahydrofuran-2-carbonitrile |
CAS No:[1355357-49-1] |
|
|
(1R,3S)-3-AMinocyclopentanol hydrochloride |
CAS No:[1279032-31-3] |
NOTE : Products protected under specific patents in certain countries are not offered for sale by us in such countries. |